Huntsman Carole
- SEC CIK
- 0002001571
In the past year, 3 open-market sale filings worth $1.71M and no purchases.
Current role at each company
- MDGL Madrigal Pharmaceuticals, Inc.Chief Commercial Officeras of Mar 6, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $1.71M
- 3 filings
- Net
- −$1.71M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Huntsman Carole as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 6, 2026 (view filing) | Mar 6 | Same day | Huntsman CaroleChief Commercial Officer | SSale | −419 | $431.94 | −$181.0K | −3.2%12.7K after | |
| Jan 26, 2026 (view filing) | Jan 26 | Same day | Huntsman CaroleChief Commercial Officer | SSale | −910 | $493.78 | −$449.3K | −9.1%9.12K after | 2 lots10b5-1 |
| Nov 21, 2025 (view filing) | Nov 21 | Same day | Huntsman CaroleChief Commercial Officer | SSale | −1.96K | $553.11 | −$1.08M | −16.3%10.0K after | 11 lots10b5-1 |
| Mar 5, 2025 (view filing) | Mar 3 | 2 days | Huntsman CaroleChief Commercial Officer | SSale | −1.83K | $325.98 | −$597.8K | −17.6%8.60K after | 9 lots10b5-1 |
| Jan 27, 2025 (view filing) | Jan 24 | 3 days | Huntsman CaroleChief Commercial Officer | SSale | −347 | $335.24 | −$116.3K | −3.2%10.4K after | |
| Nov 22, 2024 (view filing) | Nov 21 | 1 day | Huntsman CaroleChief Commercial Officer | SSale | −688 | $316.92 | −$218.0K | −6.0%10.8K after |